Cannabis Bioscience International Holdings (CBIH) EPS (Weighted Average and Diluted) (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly EPS (Weighted Average and Diluted) came in at -$0.0 in Q1 2026, up 47.06% year-on-year from -$0.0 in Q1 2025, and up 10.0% quarter-over-quarter from -$0.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) EPS (Weighted Average and Diluted) (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$0.0 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.0, up 47.06% year-over-year; the trailing twelve-month figure through Feb 2026 was -$0.0 (down 97.14% YoY), and the FY2025 annual result was -$0.0, up 16.67% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q3 2024 to a low of -$0.0 in Q2 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.0 (2023), against an average of -$0.0.
- Across the five-year window, EPS (Weighted Average and Diluted) soared 65.0% in 2024 and tumbled 368.0% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' EPS (Weighted Average and Diluted) stood at -$0.0 in 2022, then jumped by 60.05% to -$0.0 in 2023, then climbed by 20.0% to -$0.0 in 2024, then dropped by 25.0% to -$0.0 in 2025, then grew by 10.0% to -$0.0 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.00 |
| Nov 30, 2025 | 0.00 |
| Aug 31, 2025 | 0.00 |
| May 31, 2025 | 0.00 |
| Feb 28, 2025 | 0.00 |
| Nov 30, 2024 | 0.00 |
| Aug 31, 2024 | 0.00 |
| May 31, 2024 | 0.00 |
| Feb 29, 2024 | 0.00 |
| Nov 30, 2023 | 0.00 |
| Aug 31, 2023 | 0.00 |
| May 31, 2023 | 0.00 |
| Feb 28, 2023 | 0.00 |
| Nov 30, 2022 | 0.00 |